home / stock / cntg / cntg news

CNTG News and Press, Centogene N.V. From 06/29/23

Stock Information
Company Name: Centogene N.V.
Stock Symbol: CNTG
Market: NASDAQ
Website: centogene.com
Menu
CNTG CNTG Quote CNTG Short CNTG News CNTG Articles CNTG Message Board
Get CNTG Alerts

News, Short Squeeze, Breakout and More Instantly...
CNTG - RenovoRx, Immunome top healthcare gainers; BioXcel, CorMedix among losers

2023-06-29 10:10:59 ET Gainers: RenovoRx ( RNXT ) +37% . Immunome ( IMNM ) +36% .  DermTech ( DMTK ) +15% . Galera Therapeutics ( GRTX ) +9% . Oncolytics Biotech ( ONCY ) +7% . Losers: BioXcel Therapeutics ( BTA...
CNTG - RIDE, NERV and GNLN among pre-market losers

2023-06-29 08:47:24 ET BioXcel Therapeutics ( BTAI ) -67% . announces positive topline results from TRANQUILITY II phase 3 trial of BXCL501 for acute treatment of alzheimer’s disease-related agitation . CorMedix ( CRMD ) -21% on pricing $40M securities off...

CNTG - COHR and RIDE among pre-market losers

2023-06-28 08:18:51 ET AST SpaceMobile ( ASTS ) -30% on pricing upsized $59.4M equity offering. American Rebel Holdings ( AREB ) -27% . Eton Pharmaceuticals ( ETON ) -15% as FDA rejects methanol poisoning therapy . Centogene ( CNTG ) -12% ...

CNTG - CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment

Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF) based in Riyadh JV focuses on providing state-of-the-art multiomic testing services to patients, health system...
CNTG - Nasdaq notifies Centogene over non-compliance with listing rule

2023-06-14 17:37:46 ET Centogene N.V. ( NASDAQ: CNTG ) said Wednesday it had been notified by Nasdaq that it was not in compliance with the stock exchange's minimum market value of publicly held shares (MVPHS). Nasdaq requires companies to maintain a minimum MVPHS of $15 milli...

CNTG - CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 14, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“we” or the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has rec...

CNTG - Centogene GAAP EPS of -?1.19, revenue of ?47.5M

2023-05-17 01:56:13 ET Centogene press release ( NASDAQ: CNTG ): FY GAAP EPS of -Є1.19. Revenue of Є47.5M (+12.6% Y/Y). Significant expansion of gross profit margin from 32% to 42% and ongoing cost control resulted in significant improvement of net res...
CNTG - CENTOGENE Reports Full Year 2022 Financial Results

Full Year 2022 total revenues with double-digit growth of 12% at €47.5 million, in line with prior guidance Significant expansion of gross profit margin from 32% to 42% and ongoing cost control resulted in significant improvement of net results Both Pharma and Diagnostics segments ...

CNTG - CENTOGENE to Participate in Upcoming Conferences in May

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 05, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for May 2023. CENTOGENE representatives are ...

CNTG - Tempest, CVRx top healthcare gainers; Hillstream, Addus among losers

2023-04-28 10:03:38 ET Gainers: Tempest Therapeutics ( TPST ) +72% . CVRx ( CVRX ) +25% . ImmunoGen ( IMGN ) +22% . Apyx Medical ( APYX ) +17% . bluebird bio ( BLUE ) +17% . Losers: Hillstream BioPharma ( HILS ) -56%...
Previous 10 Next 10